We also included our study in T98G cells with a gain-of-function TP53 where the m7G methylation of the mutant TP53 transcript increased its chemosensitivity to temozolomide, showcasing consistent transcript decay effect of m7G and IGF2BP3 in cancer lines with diverse TP53 status. The gene discussed is IGF2BP3; the disease is cancer.